| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |